Market Size of Global Sugar-Based Excipients Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 4.60 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Sugar-Based Excipients Market Analysis
The sugar-based excipients market is projected to grow with a CAGR of 4.6% over the forecast period.
During the COVID-19 pandemic, pharmaceutical excipients companies faced significant problems, such as a shortage of medicinal items, and shutdown measures worldwide damaged the global supply chain of raw materials from manufacturing hubs. These restrictions hampered the medication research and manufacturing processes and had a significant impact on the corporations that rely on outsourcing. Moreover, the growing use of sugar-based excipients in the COVID-19 vaccines positively impacted the market. For instance, according to the review by the Connecticut Department of Health in April 2021, the Pfizer-BioNTech vaccine contains basic table sugar, generally known as sucrose, which is used as a stabilizer in vaccines. This component aids in the preservation of the molecules' form upon freezing. Thus, during the COVID-19 pandemic, the sugar-based excipients market is expected to have an adverse impact initially, later due to the use of sugar-based excipients in COVID-19 drug and vaccine formulations which is likely to gain market growth over the study period.
The major factor attributing to the growth of the market is the increasing use of co-processed excipients, the rapid growth of the generic market, and the increasing development of orally disintegrating tablets. For instance, as per the report published by the journal of APhP in December 2022, new combinations of existing excipients are an interesting option for improving excipient functionality which includes pleasant taste, mouth feel, and sweetness in orally disintegrating tablets. Thus, due to the above benefits of the co-processed excipient, the demand for sugar-based excipients is expected to grow, as it is one of the ingredients in the pharmaceutical product, thereby boosting the market growth.
Furthermore, the growing preference for orally disintegrating tablets and their development is boosting the market. Orally disintegrating tablets differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. As the number of geriatric population and pediatric patients increases, the demand for orally disintegrating tablets is increasing. For instance, according to the study published by MDPI in August 2022, saccharides and sugar alcohols have long been of interest in the area of orodispersible formulations due to their high-water solubility and taste-improving properties. As a result, several excipient combinations developed to manufacture orally dispersible dosage forms contain monosaccharides and/or their respective alcohols. Sugars or sugar alcohols, together with other excipients, are used to ensure the tablets' uniformity and structural integrity. The market for sugar-based excipients is therefore projected to rise as a result of the aforementioned advantages of sugar-based excipients in orally dispersible tablets.
However, the stringent regulatory requirements for sugar-based excipient products are expected to restrain market growth.